Side Effect: Myocarditis as a Potential Side Effect of mRNA Vaccines

Myocarditis, characterized by inflammation of the myocardium, arises from diverse infectious and noninfectious causes. It involves a complex interplay between the immune system, triggers, and myocardial injury. Infectious Myocarditis often results from viral, bacterial, fungal, or parasitic infections. Myocarditis has emerged as a rare but significant adverse effect of mRNA COVID-19 vaccines, predominantly affecting younger males. The pathophysiology of vaccine-related Myocarditis remains under investigation. Prompt recognition and management of Myocarditis are crucial. Healthcare professionals should maintain a high index of suspicion for Myocarditis in patients with symptoms suggestive of cardiac involvement, irrespective of COVID-19 infection or vaccination status. Thorough clinical assessment and diagnostic testing, including cardiac biomarkers and imaging studies, are imperative. Continued research is warranted to elucidate myocarditis mechanisms and develop targeted preventive strategies. Collaborative efforts among researchers, clinicians, and public health authorities are essential for advancing knowledge and improving patient care.